JP2021505197A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021505197A5 JP2021505197A5 JP2020550034A JP2020550034A JP2021505197A5 JP 2021505197 A5 JP2021505197 A5 JP 2021505197A5 JP 2020550034 A JP2020550034 A JP 2020550034A JP 2020550034 A JP2020550034 A JP 2020550034A JP 2021505197 A5 JP2021505197 A5 JP 2021505197A5
- Authority
- JP
- Japan
- Prior art keywords
- gene
- weeks
- minutes
- streptococcus
- microorganism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 244000005700 microbiome Species 0.000 claims 48
- 108090000623 proteins and genes Proteins 0.000 claims 44
- 230000001147 anti-toxic effect Effects 0.000 claims 18
- 239000002773 nucleotide Substances 0.000 claims 10
- 125000003729 nucleotide group Chemical group 0.000 claims 10
- 230000030833 cell death Effects 0.000 claims 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 6
- 210000004369 blood Anatomy 0.000 claims 6
- 239000008280 blood Substances 0.000 claims 6
- 230000004048 modification Effects 0.000 claims 6
- 238000012986 modification Methods 0.000 claims 6
- 210000002966 serum Anatomy 0.000 claims 6
- 241000194017 Streptococcus Species 0.000 claims 5
- 102000004169 proteins and genes Human genes 0.000 claims 5
- -1 sprG Proteins 0.000 claims 5
- 108010006533 ATP-Binding Cassette Transporters Proteins 0.000 claims 4
- 239000000589 Siderophore Substances 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 210000002381 plasma Anatomy 0.000 claims 4
- 235000018102 proteins Nutrition 0.000 claims 4
- 102000005416 ATP-Binding Cassette Transporters Human genes 0.000 claims 3
- 241000186427 Cutibacterium acnes Species 0.000 claims 3
- 101710198363 Iron-regulated surface determinant protein A Proteins 0.000 claims 3
- 241000589614 Pseudomonas stutzeri Species 0.000 claims 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 3
- 241000191967 Staphylococcus aureus Species 0.000 claims 3
- 241000192086 Staphylococcus warneri Species 0.000 claims 3
- 230000004075 alteration Effects 0.000 claims 3
- 230000001580 bacterial effect Effects 0.000 claims 3
- 230000002500 effect on skin Effects 0.000 claims 3
- 230000002949 hemolytic effect Effects 0.000 claims 3
- 230000001939 inductive effect Effects 0.000 claims 3
- 229910052742 iron Inorganic materials 0.000 claims 3
- 230000001717 pathogenic effect Effects 0.000 claims 3
- 230000001105 regulatory effect Effects 0.000 claims 3
- 241000894007 species Species 0.000 claims 3
- 102000021527 ATP binding proteins Human genes 0.000 claims 2
- 108091011108 ATP binding proteins Proteins 0.000 claims 2
- 108010078791 Carrier Proteins Proteins 0.000 claims 2
- 102000014914 Carrier Proteins Human genes 0.000 claims 2
- 102000003712 Complement factor B Human genes 0.000 claims 2
- 108090000056 Complement factor B Proteins 0.000 claims 2
- 241000158523 Corynebacterium striatum Species 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 2
- 108090000790 Enzymes Proteins 0.000 claims 2
- 101100285515 Escherichia coli (strain K12) hokD gene Proteins 0.000 claims 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- 102000004157 Hydrolases Human genes 0.000 claims 2
- 108090000604 Hydrolases Proteins 0.000 claims 2
- 101710198364 Iron-regulated surface determinant protein B Proteins 0.000 claims 2
- 108090000988 Lysostaphin Proteins 0.000 claims 2
- 102000003939 Membrane transport proteins Human genes 0.000 claims 2
- 108090000301 Membrane transport proteins Proteins 0.000 claims 2
- 241001529936 Murinae Species 0.000 claims 2
- 101100468245 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) relF gene Proteins 0.000 claims 2
- DQDAFHPRTISFHV-WVHVYWPXSA-N P(=O)(O)(O)C(N(C=O)C1[C@H](O)[C@H](O)[C@H](O1)CO)C(=O)O Chemical compound P(=O)(O)(O)C(N(C=O)C1[C@H](O)[C@H](O)[C@H](O1)CO)C(=O)O DQDAFHPRTISFHV-WVHVYWPXSA-N 0.000 claims 2
- 108010069341 Phosphofructokinases Proteins 0.000 claims 2
- 241000218904 Pseudomonas oryzihabitans Species 0.000 claims 2
- 101100113004 Schizosaccharomyces pombe (strain 972 / ATCC 24843) fta1 gene Proteins 0.000 claims 2
- 241000193985 Streptococcus agalactiae Species 0.000 claims 2
- 241001134658 Streptococcus mitis Species 0.000 claims 2
- 108090000992 Transferases Proteins 0.000 claims 2
- 235000001014 amino acid Nutrition 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 239000010941 cobalt Substances 0.000 claims 2
- 229910017052 cobalt Inorganic materials 0.000 claims 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 230000014509 gene expression Effects 0.000 claims 2
- 150000003278 haem Chemical class 0.000 claims 2
- 239000006041 probiotic Substances 0.000 claims 2
- 230000000529 probiotic effect Effects 0.000 claims 2
- 235000018291 probiotics Nutrition 0.000 claims 2
- 101150065460 relK gene Proteins 0.000 claims 2
- 101150075098 sbnA gene Proteins 0.000 claims 2
- 238000003786 synthesis reaction Methods 0.000 claims 2
- 101150001496 yoeB gene Proteins 0.000 claims 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 claims 1
- HLXHCNWEVQNNKA-UHFFFAOYSA-N 5-methoxy-2,3-dihydro-1h-inden-2-amine Chemical compound COC1=CC=C2CC(N)CC2=C1 HLXHCNWEVQNNKA-UHFFFAOYSA-N 0.000 claims 1
- 101000768957 Acholeplasma phage L2 Uncharacterized 37.2 kDa protein Proteins 0.000 claims 1
- 101000823746 Acidianus ambivalens Uncharacterized 17.7 kDa protein in bps2 3'region Proteins 0.000 claims 1
- 101000916369 Acidianus ambivalens Uncharacterized protein in sor 5'region Proteins 0.000 claims 1
- 241000588626 Acinetobacter baumannii Species 0.000 claims 1
- 101000769342 Acinetobacter guillouiae Uncharacterized protein in rpoN-murA intergenic region Proteins 0.000 claims 1
- 241000122229 Acinetobacter johnsonii Species 0.000 claims 1
- 101000823696 Actinobacillus pleuropneumoniae Uncharacterized glycosyltransferase in aroQ 3'region Proteins 0.000 claims 1
- 101000786513 Agrobacterium tumefaciens (strain 15955) Uncharacterized protein outside the virF region Proteins 0.000 claims 1
- 108010031025 Alanine Dehydrogenase Proteins 0.000 claims 1
- 101000618005 Alkalihalobacillus pseudofirmus (strain ATCC BAA-2126 / JCM 17055 / OF4) Uncharacterized protein BpOF4_00885 Proteins 0.000 claims 1
- 102100020724 Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Human genes 0.000 claims 1
- 108020005544 Antisense RNA Proteins 0.000 claims 1
- 241000532370 Atla Species 0.000 claims 1
- 101000967489 Azorhizobium caulinodans (strain ATCC 43989 / DSM 5975 / JCM 20966 / LMG 6465 / NBRC 14845 / NCIMB 13405 / ORS 571) Uncharacterized protein AZC_3924 Proteins 0.000 claims 1
- 101000823761 Bacillus licheniformis Uncharacterized 9.4 kDa protein in flaL 3'region Proteins 0.000 claims 1
- 101000819719 Bacillus methanolicus Uncharacterized N-acetyltransferase in lysA 3'region Proteins 0.000 claims 1
- 101000789586 Bacillus subtilis (strain 168) UPF0702 transmembrane protein YkjA Proteins 0.000 claims 1
- 101000792624 Bacillus subtilis (strain 168) Uncharacterized protein YbxH Proteins 0.000 claims 1
- 101000790792 Bacillus subtilis (strain 168) Uncharacterized protein YckC Proteins 0.000 claims 1
- 101000819705 Bacillus subtilis (strain 168) Uncharacterized protein YlxR Proteins 0.000 claims 1
- 101000948218 Bacillus subtilis (strain 168) Uncharacterized protein YtxJ Proteins 0.000 claims 1
- 101100389345 Bacillus subtilis (strain 168) ndoA gene Proteins 0.000 claims 1
- 101000718627 Bacillus thuringiensis subsp. kurstaki Putative RNA polymerase sigma-G factor Proteins 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 101000641200 Bombyx mori densovirus Putative non-structural protein Proteins 0.000 claims 1
- 101800001318 Capsid protein VP4 Proteins 0.000 claims 1
- 108090000489 Carboxy-Lyases Proteins 0.000 claims 1
- 101000947633 Claviceps purpurea Uncharacterized 13.8 kDa protein Proteins 0.000 claims 1
- 241000186216 Corynebacterium Species 0.000 claims 1
- 241001518260 Corynebacterium minutissimum Species 0.000 claims 1
- 241000928573 Cutibacterium Species 0.000 claims 1
- 241001464975 Cutibacterium granulosum Species 0.000 claims 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 claims 1
- 101000948901 Enterobacteria phage T4 Uncharacterized 16.0 kDa protein in segB-ipI intergenic region Proteins 0.000 claims 1
- 101000805958 Equine herpesvirus 4 (strain 1942) Virion protein US10 homolog Proteins 0.000 claims 1
- 241000588722 Escherichia Species 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 101100390711 Escherichia coli (strain K12) fhuA gene Proteins 0.000 claims 1
- 101000790442 Escherichia coli Insertion element IS2 uncharacterized 11.1 kDa protein Proteins 0.000 claims 1
- 101000788354 Escherichia phage P2 Uncharacterized 8.2 kDa protein in gpA 5'region Proteins 0.000 claims 1
- 101000770304 Frankia alni UPF0460 protein in nifX-nifW intergenic region Proteins 0.000 claims 1
- 108010046584 Galactose-6-phosphate isomerase Proteins 0.000 claims 1
- 101710195346 General stress protein 20U Proteins 0.000 claims 1
- 101000797344 Geobacillus stearothermophilus Putative tRNA (cytidine(34)-2'-O)-methyltransferase Proteins 0.000 claims 1
- 101000748410 Geobacillus stearothermophilus Uncharacterized protein in fumA 3'region Proteins 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- 101000772675 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) UPF0438 protein HI_0847 Proteins 0.000 claims 1
- 101000631019 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Uncharacterized protein HI_0350 Proteins 0.000 claims 1
- 101000768938 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.9 kDa protein in int-C1 intergenic region Proteins 0.000 claims 1
- 101710108819 Heme oxygenase (staphylobilin-producing) Proteins 0.000 claims 1
- 108091007581 Heme transporters Proteins 0.000 claims 1
- 101710189804 Heme-degrading monooxygenase Proteins 0.000 claims 1
- 101000785414 Homo sapiens Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Proteins 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 101000782488 Junonia coenia densovirus (isolate pBRJ/1990) Putative non-structural protein NS2 Proteins 0.000 claims 1
- 101000811523 Klebsiella pneumoniae Uncharacterized 55.8 kDa protein in cps region Proteins 0.000 claims 1
- 101000818409 Lactococcus lactis subsp. lactis Uncharacterized HTH-type transcriptional regulator in lacX 3'region Proteins 0.000 claims 1
- 101000878851 Leptolyngbya boryana Putative Fe(2+) transport protein A Proteins 0.000 claims 1
- 108020002496 Lysophospholipase Proteins 0.000 claims 1
- 102000018697 Membrane Proteins Human genes 0.000 claims 1
- 108010052285 Membrane Proteins Proteins 0.000 claims 1
- 101000758828 Methanosarcina barkeri (strain Fusaro / DSM 804) Uncharacterized protein Mbar_A1602 Proteins 0.000 claims 1
- 101001122401 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF3 Proteins 0.000 claims 1
- 101100455668 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) lucA gene Proteins 0.000 claims 1
- 101001055788 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) Pentapeptide repeat protein MfpA Proteins 0.000 claims 1
- 101710102974 O-acetyl transferase Proteins 0.000 claims 1
- 101000740670 Orgyia pseudotsugata multicapsid polyhedrosis virus Protein C42 Proteins 0.000 claims 1
- 101000769182 Photorhabdus luminescens Uncharacterized protein in pnp 3'region Proteins 0.000 claims 1
- 241000186429 Propionibacterium Species 0.000 claims 1
- 101000961392 Pseudescherichia vulneris Uncharacterized 29.9 kDa protein in crtE 3'region Proteins 0.000 claims 1
- 241000589516 Pseudomonas Species 0.000 claims 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims 1
- 241000589540 Pseudomonas fluorescens Species 0.000 claims 1
- 101000731030 Pseudomonas oleovorans Poly(3-hydroxyalkanoate) polymerase 2 Proteins 0.000 claims 1
- 101001065485 Pseudomonas putida Probable fatty acid methyltransferase Proteins 0.000 claims 1
- 108700005075 Regulator Genes Proteins 0.000 claims 1
- 101000711023 Rhizobium leguminosarum bv. trifolii Uncharacterized protein in tfuA 3'region Proteins 0.000 claims 1
- 101000948156 Rhodococcus erythropolis Uncharacterized 47.3 kDa protein in thcA 5'region Proteins 0.000 claims 1
- 101000917565 Rhodococcus fascians Uncharacterized 33.6 kDa protein in fasciation locus Proteins 0.000 claims 1
- NAQGHJTUZRHGAC-ZZZDFHIKSA-N SAICAR Chemical compound NC1=C(C(=O)N[C@@H](CC(O)=O)C(O)=O)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 NAQGHJTUZRHGAC-ZZZDFHIKSA-N 0.000 claims 1
- 101000790284 Saimiriine herpesvirus 2 (strain 488) Uncharacterized 9.5 kDa protein in DHFR 3'region Proteins 0.000 claims 1
- 101710152534 Serine protease SplD Proteins 0.000 claims 1
- 101710152528 Serine protease SplF Proteins 0.000 claims 1
- 102100022719 Solute carrier family 2, facilitated glucose transporter member 5 Human genes 0.000 claims 1
- 101710104292 Solute carrier family 2, facilitated glucose transporter member 5 Proteins 0.000 claims 1
- 241000191940 Staphylococcus Species 0.000 claims 1
- 101100344096 Staphylococcus aureus (strain MSSA476) lukDv gene Proteins 0.000 claims 1
- 101100309556 Staphylococcus aureus (strain NCTC 8325 / PS 47) sbnB gene Proteins 0.000 claims 1
- 101100309557 Staphylococcus aureus (strain NCTC 8325 / PS 47) sbnC gene Proteins 0.000 claims 1
- 101100309558 Staphylococcus aureus (strain NCTC 8325 / PS 47) sbnD gene Proteins 0.000 claims 1
- 101100309559 Staphylococcus aureus (strain NCTC 8325 / PS 47) sbnE gene Proteins 0.000 claims 1
- 101100309560 Staphylococcus aureus (strain NCTC 8325 / PS 47) sbnF gene Proteins 0.000 claims 1
- 101100309562 Staphylococcus aureus (strain NCTC 8325 / PS 47) sbnI gene Proteins 0.000 claims 1
- 241000191963 Staphylococcus epidermidis Species 0.000 claims 1
- 241001134656 Staphylococcus lugdunensis Species 0.000 claims 1
- 241001147691 Staphylococcus saprophyticus Species 0.000 claims 1
- 241001291896 Streptococcus constellatus Species 0.000 claims 1
- 101000936719 Streptococcus gordonii Accessory Sec system protein Asp3 Proteins 0.000 claims 1
- 241000194019 Streptococcus mutans Species 0.000 claims 1
- 241000193996 Streptococcus pyogenes Species 0.000 claims 1
- 241001312524 Streptococcus viridans Species 0.000 claims 1
- 101000788499 Streptomyces coelicolor Uncharacterized oxidoreductase in mprA 5'region Proteins 0.000 claims 1
- 101001102841 Streptomyces griseus Purine nucleoside phosphorylase ORF3 Proteins 0.000 claims 1
- 101000708557 Streptomyces lincolnensis Uncharacterized 17.2 kDa protein in melC2-rnhH intergenic region Proteins 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 102000003673 Symporters Human genes 0.000 claims 1
- 108090000088 Symporters Proteins 0.000 claims 1
- 101000649826 Thermotoga neapolitana Putative anti-sigma factor antagonist TM1081 homolog Proteins 0.000 claims 1
- 108010006873 Threonine Dehydratase Proteins 0.000 claims 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims 1
- 102000014384 Type C Phospholipases Human genes 0.000 claims 1
- 108010079194 Type C Phospholipases Proteins 0.000 claims 1
- 101000827562 Vibrio alginolyticus Uncharacterized protein in proC 3'region Proteins 0.000 claims 1
- 101000778915 Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) Uncharacterized membrane protein VP2115 Proteins 0.000 claims 1
- 230000002745 absorbent Effects 0.000 claims 1
- 239000002250 absorbent Substances 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000002358 autolytic effect Effects 0.000 claims 1
- 239000003613 bile acid Substances 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 108091008324 binding proteins Proteins 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 210000000349 chromosome Anatomy 0.000 claims 1
- 239000003184 complementary RNA Substances 0.000 claims 1
- 230000034994 death Effects 0.000 claims 1
- 210000004207 dermis Anatomy 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003974 emollient agent Substances 0.000 claims 1
- 101150026161 fhuB gene Proteins 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000013355 food flavoring agent Nutrition 0.000 claims 1
- 235000003599 food sweetener Nutrition 0.000 claims 1
- 230000002538 fungal effect Effects 0.000 claims 1
- 238000012239 gene modification Methods 0.000 claims 1
- 230000005017 genetic modification Effects 0.000 claims 1
- 235000013617 genetically modified food Nutrition 0.000 claims 1
- 101150013736 gyrB gene Proteins 0.000 claims 1
- 101150048127 hlgA gene Proteins 0.000 claims 1
- 101150104841 hlgB gene Proteins 0.000 claims 1
- 230000006698 induction Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000002458 infectious effect Effects 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 239000000543 intermediate Substances 0.000 claims 1
- 101150014673 isdG gene Proteins 0.000 claims 1
- 101150020318 isdI gene Proteins 0.000 claims 1
- 101150087199 leuA gene Proteins 0.000 claims 1
- 101150109493 lrgA gene Proteins 0.000 claims 1
- 101150052880 lrgB gene Proteins 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 230000002101 lytic effect Effects 0.000 claims 1
- 101150048352 mazF gene Proteins 0.000 claims 1
- 230000002503 metabolic effect Effects 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 claims 1
- 101150012629 parE gene Proteins 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 108010031697 phosphoribosylaminoimidazole synthase Proteins 0.000 claims 1
- 235000013406 prebiotics Nutrition 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 229940055019 propionibacterium acne Drugs 0.000 claims 1
- 101150112110 sceD gene Proteins 0.000 claims 1
- 101150057107 sigB gene Proteins 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 101150076089 splD gene Proteins 0.000 claims 1
- 101150081576 splF gene Proteins 0.000 claims 1
- 101150030919 srtB gene Proteins 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- 239000003765 sweetening agent Substances 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
- 230000002103 transcriptional effect Effects 0.000 claims 1
- 108700026220 vif Genes Proteins 0.000 claims 1
- 239000000080 wetting agent Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024044541A JP2024075688A (ja) | 2017-12-05 | 2024-03-21 | 微生物感染を防ぐための方法および組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762594943P | 2017-12-05 | 2017-12-05 | |
| US62/594,943 | 2017-12-05 | ||
| PCT/US2018/063880 WO2019113096A1 (en) | 2017-12-05 | 2018-12-04 | Methods and compositions to prevent microbial infection |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024044541A Division JP2024075688A (ja) | 2017-12-05 | 2024-03-21 | 微生物感染を防ぐための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021505197A JP2021505197A (ja) | 2021-02-18 |
| JP2021505197A5 true JP2021505197A5 (enExample) | 2022-01-11 |
| JP7460531B2 JP7460531B2 (ja) | 2024-04-02 |
Family
ID=66658442
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020550034A Active JP7460531B2 (ja) | 2017-12-05 | 2018-12-04 | 微生物感染を防ぐための方法および組成物 |
| JP2024044541A Pending JP2024075688A (ja) | 2017-12-05 | 2024-03-21 | 微生物感染を防ぐための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024044541A Pending JP2024075688A (ja) | 2017-12-05 | 2024-03-21 | 微生物感染を防ぐための方法および組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12163135B2 (enExample) |
| EP (1) | EP3720458B1 (enExample) |
| JP (2) | JP7460531B2 (enExample) |
| CN (2) | CN111918960B (enExample) |
| AU (2) | AU2018379996A1 (enExample) |
| CA (1) | CA3084954A1 (enExample) |
| MX (1) | MX2020005875A (enExample) |
| PH (1) | PH12020550941A1 (enExample) |
| WO (1) | WO2019113096A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104805066B (zh) * | 2015-05-18 | 2018-04-24 | 武汉菲吉乐科生物科技有限公司 | 一种葡萄球菌裂解酶及其应用 |
| TWI718402B (zh) * | 2018-08-16 | 2021-02-11 | 葡萄王生技股份有限公司 | 副乾酪乳酸桿菌gks6之活性物質、含其之組合物及其促進長壽之用途 |
| EP3984546A4 (en) * | 2019-05-15 | 2023-09-27 | Universidad de Granada | Gene therapy with the genes hokd and ldrb for cancer treatments |
| EP3996510A4 (en) * | 2019-07-08 | 2023-08-09 | BioPlx, Inc. | LIVING BIOTHERAPEUTIC COMPOSITIONS AND PROCESSES |
| WO2021163223A1 (en) * | 2020-02-10 | 2021-08-19 | The Research Foundation For The State University Of New York | Using resilient systems inference for estimating hospital acquired infection prevention infrastructure performance |
| EP4110269A4 (en) | 2020-02-28 | 2024-01-17 | Emory University | PENTAGALLOYL GLUCOSE FROM SCHINUS PLANTS AND METHOD OF USE |
| JP2023528476A (ja) * | 2020-06-02 | 2023-07-04 | バイオピーエルエックス，インコーポレイティド | 組み換え微生物においてゲノムに安定に組み込むための方法 |
| CN111926048B (zh) * | 2020-07-20 | 2023-09-26 | 广东省微生物研究所（广东省微生物分析检测中心） | 烯丙基硫醚在制备促进铜绿假单胞菌叶酸生物合成制剂中的应用 |
| WO2023023560A1 (en) * | 2021-08-17 | 2023-02-23 | Contrafect Corporation | New uses |
| US12535933B2 (en) | 2021-11-16 | 2026-01-27 | Benuka Health, Llc | Systems, methods and devices for aiding in the decolonization of bacteria |
| CN114015622A (zh) * | 2021-12-14 | 2022-02-08 | 塔里木大学 | 无乳链球菌培养基及其制备方法 |
| CN114214354A (zh) * | 2021-12-31 | 2022-03-22 | 天津科技大学 | 一种双载体表达体系及其构建方法与应用 |
| CN116617373A (zh) * | 2022-02-14 | 2023-08-22 | 菲吉乐科(南京)生物科技有限公司 | 一种高效葡萄球菌噬菌体粉剂及其制备方法 |
| CN116179654B (zh) * | 2022-12-30 | 2023-09-15 | 军事科学院军事医学研究院环境医学与作业医学研究所 | 一种检测水中镉离子的滚环扩增检测体系及其应用 |
| CN117106674B (zh) * | 2023-10-23 | 2024-03-08 | 新益(天津)生物科技有限责任公司 | 一株能够降低尿酸、修复女性私处微生态平衡的植物乳杆菌opb15和应用 |
| CN119055779B (zh) * | 2024-07-31 | 2025-11-21 | 中国科学技术大学 | 金黄色葡萄球菌毒素蛋白相关基因sa1833/sa1832在治疗金黄色葡萄球菌感染中的应用 |
Family Cites Families (139)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4133875A (en) | 1978-02-23 | 1979-01-09 | Forsyth Dental Infirmary For Children | Method of controlling dental caries with streptococcus mutans mutant strains |
| US4548807A (en) | 1983-08-03 | 1985-10-22 | Geoffrey J. Westfall | Mastitis prevention |
| US4716032A (en) | 1983-08-03 | 1987-12-29 | Geoffrey J. Westfall | Aerosol spray composition for mastitis prevention |
| AU7232087A (en) | 1986-03-26 | 1987-10-20 | Genexpress Aps | Biological containment |
| DE69310339T2 (de) | 1993-02-19 | 1997-08-21 | Philippe Djian | Präparate, die Corneozyt Proteine enthalten |
| US5733540A (en) | 1995-03-08 | 1998-03-31 | Lee; Peter Poon-Hang | Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| US5607672A (en) | 1995-06-07 | 1997-03-04 | University Of Florida Research Foundation, Inc. | Replacement therapy for dental caries |
| ATE312934T1 (de) | 1995-06-07 | 2005-12-15 | Univ Washington | Rekombinant bakterielle system mit umweltbeschränkte lebensfähigkeit |
| US6593114B1 (en) * | 1996-01-05 | 2003-07-15 | Human Genome Sciences, Inc. | Staphylococcus aureus polynucleotides and sequences |
| US6737248B2 (en) | 1996-01-05 | 2004-05-18 | Human Genome Sciences, Inc. | Staphylococcus aureus polynucleotides and sequences |
| GB9604045D0 (en) | 1996-02-26 | 1996-04-24 | Smithkline Beecham Plc | Novel compounds |
| AUPN880996A0 (en) | 1996-03-20 | 1996-04-18 | Arnott's Biscuits Limited | Selection and/or enhancement of resident microorganisms in the gastrointestinal tract |
| US6645506B1 (en) | 1997-04-18 | 2003-11-11 | Ganeden Biotech, Inc. | Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil |
| DE69942249D1 (de) | 1998-05-07 | 2010-05-27 | Univ Bruxelles | Auf cytotoxinen basierendes biologisches einschlusssystem |
| US6461607B1 (en) | 1998-08-24 | 2002-10-08 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
| CN1670217A (zh) | 1999-02-03 | 2005-09-21 | 特瓦药厂有限公司 | 经微生物学方法制备假单胞菌酸a抗生素的方法 |
| US6417002B1 (en) * | 1999-02-11 | 2002-07-09 | Pharmacopeia, Inc. | Method for maintenance and selection of episomes |
| CN1230206C (zh) | 2000-01-11 | 2005-12-07 | 内立蒂克斯股份有限公司 | 作为生产生物复合材料的生物可降解基质的聚合物混合物 |
| WO2001095876A1 (en) | 2000-06-09 | 2001-12-20 | Baylor College Of Medicine | The combination of antimicrobial agents and bacterial interference to coat medical devices |
| US6551828B1 (en) * | 2000-06-28 | 2003-04-22 | Protemation, Inc. | Compositions and methods for generating expression vectors through site-specific recombination |
| AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| AU2001286741A1 (en) | 2000-08-25 | 2002-03-04 | Trustees Of Tufts College | Methods and compositions for potentiating antibiotic action against persistent/tolerant pathogenic microorganisms |
| US7623971B2 (en) | 2000-09-25 | 2009-11-24 | Acuabiotec Llc | Method, system and computer program product for technical management and biocontrol of disease in animal production systems |
| US20020192741A1 (en) | 2000-09-28 | 2002-12-19 | Mckillip John L. | Selective medium for gram-positive bacteria |
| US6660262B2 (en) | 2001-09-28 | 2003-12-09 | Bovine Health Products, Inc. | Broad spectrum antimicrobial compound and treatment |
| ATE516356T1 (de) * | 2001-12-21 | 2011-07-15 | Biosynexus Inc | Gestutzes lysostaphin-molekül mit verbesserter staphylolytischer wirkung |
| US20040241150A1 (en) | 2002-12-19 | 2004-12-02 | Hargis Billy M. | Defined competitive exclusion cultures for food borne pathogens |
| US7482023B2 (en) | 2003-01-03 | 2009-01-27 | Sca Hygiene Products Ab | Hygiene tissue with lactic acid producing bacterial strains |
| ES2395404T3 (es) | 2004-05-14 | 2013-02-12 | Optimer Pharmaceuticals, Inc. | Tratamiento de las enfermedades asociadas al uso de antibióticos |
| US8729013B2 (en) | 2004-08-26 | 2014-05-20 | The University Of Western Ontario | Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus |
| US7627437B2 (en) | 2005-01-14 | 2009-12-01 | Idaho Research Foundation | Categorization of microbial communities |
| US20060257373A1 (en) | 2005-05-10 | 2006-11-16 | National Chung Hsing University | Antifungal formulation containing Streptomyces s.p.p., method for preparing the composition and relevant use |
| KR100844581B1 (ko) * | 2005-05-17 | 2008-07-09 | 주식회사 뉴젝스 | 혈청반응성 프로모터를 가진 리포터 아데노바이러스를 이용한 고속생리활성 물질의 검색 방법 |
| US8682619B2 (en) * | 2005-12-14 | 2014-03-25 | The Invention Science Fund I, Llc | Device including altered microorganisms, and methods and systems of use |
| US8852916B2 (en) | 2010-01-22 | 2014-10-07 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with microorganisms |
| US20100260794A1 (en) | 2006-03-20 | 2010-10-14 | Vrije Universiteit Brussel | Live attenuated salmonella vaccine |
| US20080107699A1 (en) | 2006-10-25 | 2008-05-08 | Mark Spigelman | Method of using topical probiotics for the inhibition of surface contamination by a pathogenic microorganism and composition therefor |
| GB0624340D0 (en) | 2006-12-06 | 2007-01-17 | Nature Therapeutics Ltd | Antimicrobial composition |
| WO2008077229A1 (en) | 2006-12-22 | 2008-07-03 | Luquet Francois-Marie | Growth inhibition of microorganisms by lactic acid bacteria |
| EP2124976B1 (en) | 2006-12-22 | 2011-09-28 | Bio-K Plus International Inc. | Growth inhibition and elimination of methicillin-resistant staphylococcus aureus by lactic acid bacteria |
| EP2229432A4 (en) | 2007-09-05 | 2011-05-11 | Inst Nat Rech Scient | ANTIMICROBIAL ACTIVITY OF BACTERIOCIN-PRODUCING MILKY ACID BACTERIA |
| US20110008303A1 (en) | 2008-03-17 | 2011-01-13 | Cedars-Sinai Medical Center | Methods for treatment and prevention of mrsa/mssa |
| US9636196B2 (en) | 2008-06-13 | 2017-05-02 | ProBiora Health, LLC | Use of hydrogen peroxide-producing bacteria for tooth whitening |
| WO2009152298A1 (en) | 2008-06-13 | 2009-12-17 | Zeus Scientific, Inc. | Methods, compositions and and diagnostic kits for the detection and treatment for staphylococcal nasal decolonization using achromopeptidase |
| US9700611B2 (en) | 2008-06-23 | 2017-07-11 | Mississippi State University | Live attenuated catfish vaccine and method of making |
| GB2475005A (en) | 2008-08-01 | 2011-05-04 | Ondine Int Ltd | Composition and method for treatment of mrsa |
| WO2010036876A2 (en) | 2008-09-25 | 2010-04-01 | New York University | Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota |
| WO2010123599A2 (en) | 2009-01-23 | 2010-10-28 | The Board Of Trustees Of The University Of Illinois | Anti-bacterial compositions and methods including targeting virulence factors of staphylococcus aureus |
| MX355507B (es) | 2009-03-09 | 2018-04-19 | Bioatla Llc | Proteinas mirac. |
| GB0909909D0 (en) | 2009-06-09 | 2009-07-22 | Chrisal Nv | Microcapsules containing microrgnisms |
| WO2011005756A1 (en) | 2009-07-06 | 2011-01-13 | Puretech Ventures, Llc | Delivery of agents targeted to microbiota niches |
| MX348611B (es) | 2009-12-31 | 2017-06-21 | Milton Trachtman Ira | Forma de dosificación oral para usarse en el tratamiento de enfermedad inflamatoria de intestino debido a una infección bacteriana. |
| WO2011085367A2 (en) | 2010-01-11 | 2011-07-14 | Oragenics, Inc. | Non-replicating microorganisms as post-biotics |
| WO2013052174A2 (en) | 2011-06-06 | 2013-04-11 | The Trustees Of The University Of Pennsylvania | Methods for preventing and treating staphylococcus aureus colonization, infection, and disease |
| US9107938B2 (en) | 2010-09-30 | 2015-08-18 | The Board Of Trustees Of The University Of Arkansas | Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads |
| CA2818827C (en) | 2010-11-23 | 2024-02-13 | Pantheryx, Inc. | Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications |
| US10010568B2 (en) | 2011-02-04 | 2018-07-03 | Katherine Rose Kovarik | Method and system for reducing the likelihood of a spirochetes infection in a human being |
| US10111913B2 (en) | 2011-02-04 | 2018-10-30 | Joseph E. Kovarik | Method of reducing the likelihood of skin cancer in an individual human being |
| US10314865B2 (en) | 2011-02-04 | 2019-06-11 | Katherine Rose Kovarik | Method and system for treating cancer and other age-related diseases by extending the healthspan of a human |
| EP2693887B1 (en) | 2011-04-06 | 2020-10-28 | The Board of Regents of the University of Texas System | Modulating bacterial mam polypeptides in pathogenic disease |
| WO2012150269A1 (en) | 2011-05-03 | 2012-11-08 | Dupont Nutrition Biosciences Aps | Probiotic bacteria for the topical treatment of skin disorders |
| EP3777885A1 (en) | 2011-06-19 | 2021-02-17 | New York University | Methods of treating and preventing staphylococcus aureus infections and associated conditions |
| ES2674583T3 (es) | 2011-06-30 | 2018-07-02 | Exxonmobil Research And Engineering Company | Regulación de genes de toxina y antitoxina para el confinamiento biológico |
| EP2731600A4 (en) | 2011-07-13 | 2015-08-26 | Microbiotix Inc | INHIBITORS OF THE TYPE III BACTERIAL SECRETION SYSTEM |
| CN102887952A (zh) | 2011-07-21 | 2013-01-23 | 广州瑞博奥生物科技有限公司 | 具有双重结合活性的抗MRSA-PBP 2a的单克隆抗体 |
| EP2734229B1 (en) | 2011-07-22 | 2019-01-02 | Novadigm Therapeutics, Inc. | Methods and copositions for vaccinating against staphylococcus aureus |
| WO2013050590A1 (en) * | 2011-10-07 | 2013-04-11 | Universite De Rennes 1 | Spra1 antimicrobial peptides and uses thereof |
| CN104105471B (zh) | 2012-02-14 | 2018-03-13 | 宝洁公司 | 皮肤共生益生元剂和包含其的组合物的局部使用 |
| CA2865620A1 (en) | 2012-03-05 | 2013-09-12 | University Of Maryland, Baltimore | Multivalent vaccine protection from staphylococcus aureus infection |
| GB201206599D0 (en) | 2012-04-13 | 2012-05-30 | Univ Manchester | Probiotic bacteria |
| AU2013252888B2 (en) | 2012-04-26 | 2018-06-14 | University Of Chicago | Compositions and methods related to antibodies that neutralize coagulase activity during Staphylococcus aureus disease |
| ES2728782T3 (es) * | 2012-05-25 | 2019-10-28 | Univ California | Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN |
| MX2015006491A (es) | 2012-11-23 | 2015-12-03 | Seres Health Inc | Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas. |
| EP2941259A4 (en) | 2013-01-04 | 2016-07-27 | Second Genome Inc | MIKROBIOMMODULATIONSINDEX |
| MX369877B (es) | 2013-02-04 | 2019-11-25 | Seres Therapeutics Inc | Composiciones y metodos. |
| WO2014124226A1 (en) | 2013-02-07 | 2014-08-14 | The Rockefeller University | Sequence specific antimicrobials |
| US10413577B2 (en) | 2013-02-22 | 2019-09-17 | The Regents Of The University Of California | Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life |
| WO2014137906A1 (en) | 2013-03-05 | 2014-09-12 | Intelligent Medical Devices, Inc. | Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of mrsa, mssa, staphylococcus markers, and the antibiotic resistance gene mec a |
| US9101597B2 (en) | 2013-03-14 | 2015-08-11 | The Administration Of The Tulane Educational Fund | Immunoprotective primary mesenchymal stem cells and methods |
| US10150982B2 (en) | 2013-03-14 | 2018-12-11 | Second Genome, Inc. | Microbial ecology shift assay |
| JP2016519664A (ja) | 2013-03-15 | 2016-07-07 | セレス セラピューティクス インコーポレイテッド | ネットワークを基にした微生物組成物及び方法 |
| US9511100B2 (en) | 2013-06-05 | 2016-12-06 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| CN110420316A (zh) | 2013-06-18 | 2019-11-08 | 纽约大学 | 参与金黄色葡萄球菌杀白细胞素的细胞毒性的细胞因素：新型治疗靶点 |
| CN110564663B (zh) | 2013-08-19 | 2023-03-10 | 辛格隆股份公司 | 微生物的受控生长 |
| WO2015048364A1 (en) | 2013-09-27 | 2015-04-02 | President And Fellows Of Harvard College | Recombinant cells and organisms having persistent nonstandard amino acid dependence and methods of making them |
| US10058576B2 (en) * | 2013-10-03 | 2018-08-28 | The Trustees Of The University Of Pennsylvania | Compositions and methods comprising a defined microbiome and methods of use thereof |
| WO2015069682A2 (en) | 2013-11-05 | 2015-05-14 | President And Fellows Of Harvard College | Precise microbiota engineering at the cellular level |
| MX367109B (es) | 2013-11-25 | 2019-08-05 | Seres Therapeutics Inc | Composiciones bacterianas sinergicas y sus metodos de produccion y usos. |
| AU2014363987A1 (en) | 2013-12-09 | 2016-06-30 | Janssen Biotech, Inc. | Compositions and methods for phagocyte delivery of anti-staphylococcal agents |
| EP3903824A1 (en) | 2014-01-10 | 2021-11-03 | The Regents of The University of California | Skin probiotic |
| CN106456678A (zh) | 2014-04-15 | 2017-02-22 | Ao生物医学有限责任公司 | 氨氧化型亚硝化单胞菌菌株d23 |
| US20170081707A1 (en) | 2014-05-06 | 2017-03-23 | Phylagen, Inc. | Monitoring and managing a facility microbiome |
| EP4299122A3 (en) | 2014-05-07 | 2024-03-27 | The Regents of The University of California | Compositions and methods for treating skin and mucous membrane diseases |
| ES2929579T3 (es) | 2014-05-30 | 2022-11-30 | Azitra Inc | Tratamiento terapéutico de enfermedades cutáneas con microorganismos cutáneos comensales recombinantes |
| CN106572662A (zh) | 2014-06-27 | 2017-04-19 | 凯恩生物科技有限公司 | 抗微生物‑抗生物膜组合物及其作为个人护理产品的使用方法 |
| US9760676B2 (en) | 2014-10-21 | 2017-09-12 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions |
| EP4529950A3 (en) | 2014-10-31 | 2025-08-20 | Pendulum Therapeutics, Inc. | Methods and compositions relating to microbial treatment |
| WO2016066784A1 (en) * | 2014-10-31 | 2016-05-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Cyclic antimicrobial pseudopeptides and uses thereof |
| US9688967B2 (en) | 2014-12-05 | 2017-06-27 | Synlogic, Inc. | Bacteria engineered to treat diseases associated with hyperammonemia |
| MX383245B (es) * | 2014-12-05 | 2025-03-13 | Synlogic Operating Co Inc | Bacterias modificadas para tratar enfermedades asociadas con hiperamonemia. |
| US20160206666A1 (en) | 2014-12-22 | 2016-07-21 | Synlogic, Inc. | Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier |
| EP3064072A1 (en) | 2015-02-11 | 2016-09-07 | AB-Biotics S.A. | Probiotic lactobacillus strains for use in treating urinary tract infections |
| KR20170121291A (ko) | 2015-03-02 | 2017-11-01 | 신로직 인코포레이티드 | 감소된 창자 염증 및/또는 강화된 창자 점막 장벽으로부터 이익을 얻는 질병을 치료하기 위해 공학처리된 박테리아 |
| WO2016172196A1 (en) | 2015-04-20 | 2016-10-27 | Pätzold Bernhard | Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains |
| WO2016172686A1 (en) | 2015-04-24 | 2016-10-27 | The Translational Genomics Research Institute | Compositions and methods for augmenting the nasal microbiome |
| WO2016177682A1 (en) | 2015-05-06 | 2016-11-10 | Snipr Technologies Limited | Altering microbial populations & modifying microbiota |
| EP3882259B1 (en) | 2015-05-13 | 2026-01-28 | Synlogic Operating Company, Inc. | Bacteria engineered to reduce hyperphenylalaninemia |
| EP3294757B1 (en) | 2015-05-13 | 2023-12-27 | Synlogic Operating Company, Inc. | Bacteria engineered to treat a disease or disorder |
| AU2016274311A1 (en) | 2015-06-10 | 2018-01-18 | Synlogic Operating Company, Inc. | Bacteria engineered to treat diseases associated with hyperammonemia |
| AU2016279062A1 (en) | 2015-06-18 | 2019-03-28 | Omar O. Abudayyeh | Novel CRISPR enzymes and systems |
| WO2016210373A2 (en) * | 2015-06-24 | 2016-12-29 | Synlogic, Inc. | Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof |
| WO2016210384A2 (en) | 2015-06-25 | 2016-12-29 | Synlogic, Inc. | Bacteria engineered to treat metabolic diseases |
| WO2017008018A1 (en) | 2015-07-09 | 2017-01-12 | Massachusetts Institute Of Technology | Genetically engineered sensors for in vivo detection of bleeding |
| EP3328988A1 (en) | 2015-07-31 | 2018-06-06 | Synlogic, Inc. | Bacteria engineered to treat disorders involving propionate catabolism |
| WO2017059245A2 (en) | 2015-09-30 | 2017-04-06 | Trustees Of Boston University | Deadman and passcode microbial kill switches |
| EP3368050A1 (en) | 2015-10-26 | 2018-09-05 | Crestovo Holdings LLC | Compositions and methods for fecal microbiota-related therapy |
| EP3379935A4 (en) | 2015-11-25 | 2019-08-28 | Memorial Sloan-Kettering Cancer Center | METHOD AND COMPOSITIONS FOR REDUCING VANCOMYCIN RESISTANT ENTEROKOKKEN |
| RU2662310C9 (ru) | 2015-12-04 | 2018-09-21 | Виктор Вениаминович Тец | Средство (варианты) и способы восстановления микрофлоры |
| LT6463B (lt) | 2015-12-10 | 2017-10-10 | Uab "Probiosanus" | Probiotinių bakterijų (pb) gyvybingumo ir stabilumo padidinimas detergentų turinčiuose asmens higienos ir buities priežiūros produktuose |
| GB201522153D0 (en) * | 2015-12-15 | 2016-01-27 | Univ Southampton | Meningococcal infection and modified neisseria lactamica |
| WO2017112620A1 (en) | 2015-12-22 | 2017-06-29 | North Carolina State University | Methods and compositions for delivery of crispr based antimicrobials |
| WO2017123676A1 (en) | 2016-01-11 | 2017-07-20 | Synlogic, Inc. | Recombinant bacteria engineered to treat diseases and disorders associated with amino acid metabolism and methods of use thereof |
| US10689644B2 (en) | 2016-03-17 | 2020-06-23 | Duke University | Systems and methods for genetic analysis of intractable microbes |
| EP3445330B1 (en) | 2016-04-19 | 2022-07-06 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Use of gram negative species to treat atopic dermatitis |
| WO2017182796A1 (en) | 2016-04-19 | 2017-10-26 | Genome Research Limited | Bacteriotherapy |
| EP3448398A4 (en) | 2016-04-21 | 2019-12-18 | Naked Biome, Inc. | COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES |
| WO2017210428A1 (en) | 2016-06-01 | 2017-12-07 | Crestovo Llc | Compositions and methods for treating inflammatory bowel diseases (ibds) and other disorders |
| CA3028031C (en) | 2016-06-22 | 2023-02-28 | Prodigest Bvba | Microbial carotenoids affecting gut microbial composition |
| WO2018049556A1 (en) | 2016-09-13 | 2018-03-22 | The Procter & Gamble Company | Methods of increasing microbial diversity of a skin microbiota |
| BR112019005810A2 (pt) | 2016-09-27 | 2019-06-25 | uBiome, Inc. | método para sequenciamento de microbioma melhorado para caracterizar uma afecção relacionada a micro-organismo para um usuário associado a uma amostra biológica, e método para sequenciamento de microbioma melhorado |
| WO2018094190A2 (en) | 2016-11-18 | 2018-05-24 | Sanford Burnham Prebys Medical Discovery Institute | Gut microbiota and treatment of cancer |
| US11674128B2 (en) | 2016-12-12 | 2023-06-13 | Tsinghua University | Engineering of a minimal SaCas9 CRISPR/Cas system for gene editing and transcriptional regulation optimized by enhanced guide RNA |
| US11566238B2 (en) | 2016-12-15 | 2023-01-31 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for modulating growth of a genetically modified gut bacterial cell |
| FR3060393A1 (fr) | 2016-12-16 | 2018-06-22 | Nestle Skin Health Sa | Capsule comprenant un microorganisme probiotique pour utilisation dans un dispositif de production et de distribution de compositions |
| EP3358015A1 (en) | 2017-02-03 | 2018-08-08 | Eligo Bioscience | Optimized vector for delivery in microbial populations |
| WO2018152306A1 (en) | 2017-02-15 | 2018-08-23 | President And Fellows Of Harvard College | Modulation of host immune cell populations using gut microbiota |
| JP2020508357A (ja) | 2017-02-27 | 2020-03-19 | コンティニュアム グループ エルエルシー | 日焼け止め剤 |
| WO2018182515A1 (en) | 2017-03-27 | 2018-10-04 | Agency For Science, Technology And Research | Methods of modifying fungi and uses thereof |
| US20200056145A1 (en) | 2017-04-17 | 2020-02-20 | The Regents Of The University Of California | Engineered commensal bacteria and methods of use |
-
2018
- 2018-12-04 MX MX2020005875A patent/MX2020005875A/es unknown
- 2018-12-04 US US16/209,706 patent/US12163135B2/en active Active
- 2018-12-04 CN CN201880088486.5A patent/CN111918960B/zh active Active
- 2018-12-04 CA CA3084954A patent/CA3084954A1/en active Pending
- 2018-12-04 AU AU2018379996A patent/AU2018379996A1/en not_active Abandoned
- 2018-12-04 CN CN202510007125.5A patent/CN119875972A/zh active Pending
- 2018-12-04 EP EP18886851.7A patent/EP3720458B1/en active Active
- 2018-12-04 WO PCT/US2018/063880 patent/WO2019113096A1/en not_active Ceased
- 2018-12-04 JP JP2020550034A patent/JP7460531B2/ja active Active
-
2020
- 2020-06-05 PH PH12020550941A patent/PH12020550941A1/en unknown
-
2024
- 2024-03-21 JP JP2024044541A patent/JP2024075688A/ja active Pending
- 2024-12-09 US US18/973,546 patent/US20250346910A1/en active Pending
-
2025
- 2025-09-18 AU AU2025234199A patent/AU2025234199A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Crosa | Signal transduction and transcriptional and posttranscriptional control of iron-regulated genes in bacteria | |
| Schulz et al. | Regulation of the arginine deiminase system by ArgR2 interferes with arginine metabolism and fitness of Streptococcus pneumoniae | |
| Christner et al. | sarA negatively regulates S taphylococcus epidermidis biofilm formation by modulating expression of 1 MDa extracellular matrix binding protein and autolysis‐dependent release of eDNA | |
| Jakubovics et al. | Life after death: the critical role of extracellular DNA in microbial biofilms | |
| Moscoso et al. | A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus | |
| Staubitz et al. | MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance | |
| Reiß et al. | Global analysis of the Staphylococcus aureus response to mupirocin | |
| Montgomery et al. | CodY deletion enhances in vivo virulence of community-associated methicillin-resistant Staphylococcus aureus clone USA300 | |
| JP2024075688A (ja) | 微生物感染を防ぐための方法および組成物 | |
| Barrett et al. | Salivaricin P, one of a family of two-component antilisterial bacteriocins produced by intestinal isolates of Lactobacillus salivarius | |
| Rogers et al. | Adhesion by pathogenic corynebacteria | |
| Nagasawa et al. | Potential risk of spreading resistance genes within extracellular-DNA-dependent biofilms of Streptococcus mutans in response to cell envelope stress induced by sub-MICs of bacitracin | |
| Khaskheli et al. | Overexpression of small heat shock protein enhances heat-and salt-stress tolerance of Bifidobacterium longum NCC2705 | |
| Von Krueger et al. | The phosphate‐starvation response in Vibrio cholerae O1 and phoB mutant under proteomic analysis: disclosing functions involved in adaptation, survival and virulence | |
| Yan et al. | The effect of c-di-GMP (3′–5′-cyclic diguanylic acid) on the biofilm formation and adherence of Streptococcus mutans | |
| JP2024028933A (ja) | ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ）属細菌の栄養要求株 | |
| Schroll et al. | Polyamines are essential for virulence in Salmonella enterica serovar Gallinarum despite evolutionary decay of polyamine biosynthesis genes | |
| Dmitriev et al. | The intersection of the Staphylococcus aureus Rex and SrrAB regulons: an example of metabolic evolution that maximizes resistance to immune radicals | |
| Sleator et al. | Patho-biotechnology; using bad bugs to make good bugs better | |
| Cho et al. | Involvement of lipoprotein P pi A of S treptococcus gordonii in evasion of phagocytosis by macrophages | |
| Raczkowska et al. | OmpR controls Yersinia enterocolitica motility by positive regulation of flhDC expression | |
| Costechareyre et al. | Cyt toxin expression reveals an inverse regulation of insect and plant virulence factors of Dickeya dadantii | |
| EP3866820A2 (en) | Live biotherapeutics to treat and prevent lung conditions | |
| Kawada-Matsuo et al. | Two-component systems involved in susceptibility to nisin A in Streptococcus pyogenes | |
| Meng-bo et al. | Screening and characterization of bacteriostatic Bacillus. |